Connect with us

International

Flowr acquires entirety of Holigen Holdings

Published

em

Listen to this article

Flowr Corporation (FLWR on Canadian Venture Exchange) (FLWPF on OTC Markets) Monday announced plans to fully acquire Holigen Holdings with the purchase of the remaining 80,2% stake in Holigen Holdings Ltd. Holigen owns the entirety of the Portuguese company RPK Biopharma, operating in Portugal as a project of “National Interest”.

Toronto Licensed Producer (LP) Flowr Corp has issued a statement announcing its intention to purchase all the shares of Holigen Holdings Ltd. Holigen is a European-based medical cannabis company that develops large-scale cultivation facilities, with activity in Portugal, namely in Sintra and Aljustrel.

“The full acquisition of Holigen is a natural evolution of our global cannabis strategy. The combination of Flowr's cultivation and facility design know-how with Holigen's global presence, expertise in good manufacturing practices and deep pharmaceutical expertise are an excellent combination. The opportunities in Europe and the Australian-Asian medical cannabis markets are enormous and Holigen has an unrivaled scale to serve these regions,” said Flowr CEO Vinay Tolia.

In December 2018, Flowr announced the acquisition of 19,8% of Holigen. Holigen's activity in Portugal is mainly carried out through the subsidiary RPK Biopharma. The latter awaits INFARMED's validations to start production in Sintra and Aljustrel, in a production that totals more than 400 tons of cannabis per year. This project has been designated a Project of National Interest by the Portuguese government, which guarantees special treatment and priority by government agencies and access to low-cost funding.

Increase the global scale

“Over this year, we've worked closely with Holigen's management to help develop their incredible assets, notably in Aljustrel, where the company has an outdoor growing facility. Aljustrel, which should be operational in the second half of 2019 — in a project with an expected production capacity of more than 500.000 kilograms per year. This acquisition positions Flowr to succeed with two distinct and economically sustainable strategies, the flower market in Canada and the large-scale market for medical extracts worldwide”, reads the statement signed by the CEO.

transaction details

The details of the transaction are known and according to the document published by the company, the purchase of Holigen will involve 32 million redeemable and convertible preference shares of Flowr, together with an amount of about 4,27 million euros. Flowr also agreed to pay an aggregate amount of around €1,4 million to various Holigen creditors, subject to the closing of the transaction. The purchase price will still be subject to re-analysis based on Holigen's cash amounts on the closing day of the transaction.

On Tuesday, Flowr shares were quoted at 5.87 US dollars

 

 

________________________________________________________________________________________

 

If you like CannaReporter, please consider supporting independent journalism by making a donation on our Patreon account.

From just €3/month!

________________________________________________________________________________________

[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages ​​using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]
Click here to comment

Leave a comment

Your email address will not be published. Required fields are marked *

Advertising


Watch the Documentary "Patients"

Documentary Patients Laura Ramos help us grow

Mais recentes

Events1 hours ago

EVO NXT: Next Generation Products Festival returns to Malaga and Cannabis will be in the spotlight

The 2nd edition of the Business Festival for Next Generation Products, EVO NXT, returns to Malaga this...

International7 days ago

It's official: Germany is the third country in Europe to legalize the recreational use of cannabis

The Bundesrat approved today, Friday, the bill to regulate the use of cannabis for recreational purposes in the country....

BusinessCann1 weeks ago

Germany: Cannabis legalization on the brink? Bundesrat votes on bill tomorrow

Most media outlets announced the legalization of cannabis in Germany as a fait accompli, but...

National1 weeks ago

Portugal: Medicinal cannabis on Madeira Island with autonomous licensing process from the mainland

The Autonomous Region of Madeira is taking over the licensing of activities related to medicinal cannabis in the archipelago, in accordance...

International1 weeks ago

Norway: Activists send 200g of cannabis to the Prime Minister and other politicians by post

Norwegian activists from the Alliance for Human Rights-Oriented Drug Policy (AROD) sent 10 letters with 200...

Events1 weeks ago

Spain: Exponential growth of Spannabis dictates expansion to Bilbao in September

The 20th edition of Spannabis 2024, one of the oldest and largest cannabis fairs in the world, ended yesterday with...

International1 weeks ago

Morocco enters the cannabis race with the first legal cannabis harvest

The year 2023 will go down in Morocco's history as the year in which the first legal harvest of...

Hemp2 weeks ago

USA: USDA announces investment of 10 million in hemp research

The United States Department of Agriculture (USDA) recently released the “Hemp Research Needs Map” and announced a...

Interviews2 weeks ago

Jacqueline Poitras: “Doctors are painfully ignorant when it comes to cannabinoids and their effects on the human body”

Founder of 'MAMAKA- Mothers for Cannabis', an association for medical cannabis patients in Greece, Jacqueline Poitras has been a...

International2 weeks ago

Understanding the UN System & Our Role at CND67 - Midterm Review

The United Nations, in Vienna, hosts annual sessions of the Commission on Narcotic Drugs (CND). These sessions provide opportunities for organizations without...